Cargando…
Simvastatin Protects Heart from Pressure Overload Injury by Inhibiting Excessive Autophagy
Cardiac hypertrophy is an independent predictor of cardiovascular morbidity and mortality. To identify the mechanisms by which simvastatin inhibits cardiac hypertrophy induced by pressure overload, we determined effects of simvastatin on 14-3-3 protein expression and autophagic activity. Simvastatin...
Autores principales: | Su, Feifei, Shi, Miaoqian, Zhang, Jian, Zheng, Qiangsun, Zhang, Dongwei, Zhang, Wei, Wang, Haichang, Li, Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216062/ https://www.ncbi.nlm.nih.gov/pubmed/30443172 http://dx.doi.org/10.7150/ijms.28106 |
Ejemplares similares
-
MiR-223/NFAT5 signaling suppresses arterial smooth muscle cell proliferation and motility in vitro
por: Su, Feifei, et al.
Publicado: (2020) -
Simvastatin Modulates Remodeling of Kv4.3 Expression in Rat Hypertrophied Cardiomyocytes
por: Su, Feifei, et al.
Publicado: (2012) -
Autophagy Controls Nrf2-Mediated Dichotomy in Pressure Overloaded Hearts
por: Wu, Weiwei, et al.
Publicado: (2021) -
Inhibiting Receptor of Advanced Glycation End Products Attenuates Pressure Overload-Induced Cardiac Dysfunction by Preventing Excessive Autophagy
por: Gao, Wenbin, et al.
Publicado: (2018) -
Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation
por: Wang, Bin, et al.
Publicado: (2017)